bioMerieux's total assets for Q2 2026 were €5.69B, an increase of 2.13% from the previous quarter. FR:BIM total liabilities were €1.39B for the fiscal quarter, a -5.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.